UniProt ID | MK04_HUMAN | |
---|---|---|
UniProt AC | P31152 | |
Protein Name | Mitogen-activated protein kinase 4 | |
Gene Name | MAPK4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 587 | |
Subcellular Localization | Cytoplasm. Nucleus. Translocates to the cytoplasm following interaction with MAPKAPK5.. | |
Protein Description | Atypical MAPK protein. Phosphorylates microtubule-associated protein 2 (MAP2) and MAPKAPK5. The precise role of the complex formed with MAPKAPK5 is still unclear, but the complex follows a complex set of phosphorylation events: upon interaction with atypical MAPKAPK5, ERK4/MAPK4 is phosphorylated at Ser-186 and then mediates phosphorylation and activation of MAPKAPK5, which in turn phosphorylates ERK4/MAPK4. May promote entry in the cell cycle (By similarity).. | |
Protein Sequence | MAEKGDCIASVYGYDLGGRFVDFQPLGFGVNGLVLSAVDSRACRKVAVKKIALSDARSMKHALREIKIIRRLDHDNIVKVYEVLGPKGTDLQGELFKFSVAYIVQEYMETDLARLLEQGTLAEEHAKLFMYQLLRGLKYIHSANVLHRDLKPANIFISTEDLVLKIGDFGLARIVDQHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCILAEMLTGRMLFAGAHELEQMQLILETIPVIREEDKDELLRVMPSFVSSTWEVKRPLRKLLPEVNSEAIDFLEKILTFNPMDRLTAEMGLQHPYMSPYSCPEDEPTSQHPFRIEDEIDDIVLMAANQSQLSNWDTCSSRYPVSLSSDLEWRPDRCQDASEVQRDPRAGSAPLAEDVQVDPRKDSHSSSERFLEQSHSSMERAFEADYGRSCDYKVGSPSYLDKLLWRDNKPHHYSEPKLILDLSHWKQAAGAPPTATGLADTGAREDEPASLFLEIAQWVKSTQGGPEHASPPADDPERRLSASPPGRPAPVDGGASPQFDLDVFISRALKLCTKPEDLPDNKLGDLNGACIPEHPGDLVQTEAFSKERW | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
50 | Ubiquitination | CRKVAVKKIALSDAR HHHHHHHHHHCCCHH | 26.98 | - | |
58 | Phosphorylation | IALSDARSMKHALRE HHCCCHHHHHHHHHH | 33.62 | - | |
87 | Ubiquitination | VYEVLGPKGTDLQGE EEEECCCCCCCCCHH | 73.05 | - | |
138 | Ubiquitination | YQLLRGLKYIHSANV HHHHHHHHHHHHCCE | 45.01 | - | |
142 | Phosphorylation | RGLKYIHSANVLHRD HHHHHHHHCCEECCC | 16.39 | - | |
182 | Ubiquitination | VDQHYSHKGYLSEGL HHCCCCCCCCCCCCC | 43.22 | - | |
184 | Phosphorylation | QHYSHKGYLSEGLVT CCCCCCCCCCCCCCC | 16.32 | 27251275 | |
186 | Phosphorylation | YSHKGYLSEGLVTKW CCCCCCCCCCCCCCC | 22.57 | 25159151 | |
191 | Phosphorylation | YLSEGLVTKWYRSPR CCCCCCCCCCCCCCC | 22.39 | 27251275 | |
196 | Phosphorylation | LVTKWYRSPRLLLSP CCCCCCCCCCEEECC | 9.93 | 1319925 | |
206 | Phosphorylation | LLLSPNNYTKAIDMW EEECCCCHHHHHHHH | 19.09 | 25690035 | |
207 | Phosphorylation | LLSPNNYTKAIDMWA EECCCCHHHHHHHHH | 19.00 | 25690035 | |
276 | Ubiquitination | EVKRPLRKLLPEVNS HCCHHHHHHCHHCCH | 63.16 | - | |
294 | Phosphorylation | DFLEKILTFNPMDRL HHHHHHHHCCHHHHH | 25.49 | - | |
316 | Phosphorylation | HPYMSPYSCPEDEPT CCCCCCCCCCCCCCC | 26.95 | - | |
360 | Phosphorylation | CSSRYPVSLSSDLEW CCCCCCCCCCCCCCC | 20.30 | 22210691 | |
362 | Phosphorylation | SRYPVSLSSDLEWRP CCCCCCCCCCCCCCC | 17.82 | 22210691 | |
363 | Phosphorylation | RYPVSLSSDLEWRPD CCCCCCCCCCCCCCC | 52.05 | 28348404 | |
386 | Phosphorylation | QRDPRAGSAPLAEDV HCCCCCCCCCCCCCC | 26.23 | 30576142 | |
412 | Phosphorylation | SERFLEQSHSSMERA HHHHHHHHHHHHHHH | 18.89 | 22617229 | |
414 | Phosphorylation | RFLEQSHSSMERAFE HHHHHHHHHHHHHHH | 36.31 | 22617229 | |
415 | Phosphorylation | FLEQSHSSMERAFEA HHHHHHHHHHHHHHC | 21.17 | 22617229 | |
424 | Phosphorylation | ERAFEADYGRSCDYK HHHHHCCCCCCCCCC | 22.83 | - | |
427 | Phosphorylation | FEADYGRSCDYKVGS HHCCCCCCCCCCCCC | 13.64 | 28348404 | |
431 | Ubiquitination | YGRSCDYKVGSPSYL CCCCCCCCCCCHHHH | 27.20 | - | |
434 | Phosphorylation | SCDYKVGSPSYLDKL CCCCCCCCHHHHHHH | 17.41 | 29116813 | |
436 | Phosphorylation | DYKVGSPSYLDKLLW CCCCCCHHHHHHHHH | 39.77 | 25072903 | |
437 | Phosphorylation | YKVGSPSYLDKLLWR CCCCCHHHHHHHHHC | 23.46 | 25072903 | |
447 | Ubiquitination | KLLWRDNKPHHYSEP HHHHCCCCCCCCCCC | 50.44 | - | |
451 | Phosphorylation | RDNKPHHYSEPKLIL CCCCCCCCCCCEEEE | 16.22 | 29083192 | |
452 | Phosphorylation | DNKPHHYSEPKLILD CCCCCCCCCCEEEEE | 42.96 | 29083192 | |
472 | Phosphorylation | QAAGAPPTATGLADT HHCCCCCCCCCCCCC | 35.47 | - | |
479 | Phosphorylation | TATGLADTGAREDEP CCCCCCCCCCCCCCC | 27.42 | - | |
508 | Phosphorylation | QGGPEHASPPADDPE CCCCCCCCCCCCCHH | 33.07 | 29116813 | |
519 | Phosphorylation | DDPERRLSASPPGRP CCHHHCCCCCCCCCC | 25.53 | 29116813 | |
521 | Phosphorylation | PERRLSASPPGRPAP HHHCCCCCCCCCCCC | 28.40 | 22210691 | |
548 | Ubiquitination | VFISRALKLCTKPED HHHHHHHHHCCCHHH | 40.30 | - | |
560 | Ubiquitination | PEDLPDNKLGDLNGA HHHCCCCCCCCCCCC | 62.32 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
186 | S | Phosphorylation | Kinase | PAK1 | Q13153 | Uniprot |
186 | S | Phosphorylation | Kinase | PAK2 | Q13177 | Uniprot |
186 | S | Phosphorylation | Kinase | PAK3 | O75914 | Uniprot |
186 | S | Phosphorylation | Kinase | PAK-SUBFAMILY | - | GPS |
196 | S | Phosphorylation | Kinase | MAPK4 | P31152 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
186 | S | Phosphorylation |
| 18669648 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MK04_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MAPK5_HUMAN | MAPKAPK5 | physical | 23602568 | |
RB6I2_HUMAN | ERC1 | physical | 23602568 | |
TECR_HUMAN | TECR | physical | 23602568 | |
FAKD5_HUMAN | FASTKD5 | physical | 23602568 | |
FA57A_HUMAN | FAM57A | physical | 23602568 | |
PFKAP_HUMAN | PFKP | physical | 23602568 | |
PSA7_HUMAN | PSMA7 | physical | 23602568 | |
SFXN2_HUMAN | SFXN2 | physical | 23602568 | |
ACSL3_HUMAN | ACSL3 | physical | 23602568 | |
AT1A1_HUMAN | ATP1A1 | physical | 23602568 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Activation loop phosphorylation of ERK3/ERK4 by group I p21-activatedkinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated proteinkinase 5 signaling pathway."; Deleris P., Trost M., Topisirovic I., Tanguay P.L., Borden K.L.,Thibault P., Meloche S.; J. Biol. Chem. 286:6470-6478(2011). Cited for: PHOSPHORYLATION AT SER-186. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND MASSSPECTROMETRY. |